Positioning Thailand as a regional hub for medical genomics

Wang Jian, Chairman & Co-Founding father of BGI Group, proposes to determine the “Worldwide Innovation Heart for Life Science” in Thailand

Wang Jian, Chairman & Co-founder of BGI Group, lately visited Thailand to talk to Prime Minister and Minister of Defence Prayut Chan-o-cha on January 10, 2023, and talk about medical genomics and the event of life sciences with the general public sector and different organisations.

Wang Jian expressed the hope to see cooperation between authorities organisations and companions in Thailand to determine the “Worldwide Innovation Heart for Life Science” in Thailand sooner or later, as this is able to place Thailand as a regional hub for medical genomics in addition to a centre for treating thalassemia, and would put together the bottom to supply related companies to the Thai public.

Wang Jian additionally met with Anutin Charnvirakul, Deputy Prime Minister and Minister of Public Well being, and Sathit Pitutecha, Deputy Minister of Public Well being, to debate the growth of cooperation with the general public well being system and additional improvement of life sciences in Thailand.

“We really imagine that the creation of the Worldwide Innovation Heart for Life Science will lastly be achieved as a result of Thailand has many internationally recognised medical groups and a excessive degree of medical development and requirements. Moreover, Thailand additionally has nationwide insurance policies that assist improvement within the subject of genomics. As such, we’re assured that each events will broaden collaboration of their areas of experience, training and coaching, and exchanges will happen with the help of associated organisations. Because the outdated saying goes, ‘Instructing individuals fish is more practical than giving a fish to them.’ This cooperation will allow the youthful generations to maintain tempo with the event of cutting-edge applied sciences and allow the world’s main fashionable applied sciences to serve Thailand and profit the Thai public.”

Wang Jian additional acknowledged that, “BGI and Chalermchai Sri-on, Minister of Agriculture and Cooperatives, have mentioned additional cooperation round improvement, innovation and analysis. BGI has achieved success in lots of areas of China. As an illustration, it has developed the know-how to develop rice that may be sowed as soon as and harvested a number of occasions over the course of three to 5 years. This perennial rice reduces the associated fee and consumption of seeds, fertiliser and water. Power consumption, together with labour pressure, and different useful resource necessities are be lowered, leading to a lower in carbon emissions and international warming. Our discussions and research will due to this fact proceed.”

“Over the previous 20 years, I’ve held to the idea that ‘omics’ and associated applied sciences for all will profit mankind. BGI has its personal distinctive strategic considering in scientific improvement, technological innovation and industrial improvement. Moreover, we actively encourage innovation in expertise and know-how, and scale back industrial prices via large-scale developments. This, in flip, reduces incidences of illnesses and helps everybody take pleasure in a wholesome life. BGI plans to cooperate with authorities organisations and companions in Thailand to conduct preventive screening for genetic illnesses and forestall and management most cancers utilizing genetic applied sciences. In addition to, we offer help to assist acquire management over infectious illnesses all over the world. Thus, we obtain our goal of benefiting mankind at depth.”

Established in 1999 and headquartered in Shenzhen, Individuals’s Republic of China, BGI is dedicated to enjoying a key position within the Human Genome Mission. The corporate has over 10,000 workers in 100 international locations and areas worldwide. It has revealed over 4,000 analysis papers, over 400 of which seem in main scientific journals reminiscent of Nature, Science, Cell, and New England Journal of Drugs. Furthermore, it has obtained over 1,700 patents. BGI Genomics, a subsidiary of BGI, is listed on the Shenzhen Inventory Alternate. MGI Tech Co., Ltd., a subsidiary of BGI, listed on the Shanghai Inventory Alternate in 2022. In response to 2022 Nature Index, BGI ranks eighth globally and first amongst life science industrial establishments within the Asia-Pacific area.

To fight the pandemic that has raged all over the world lately, BGI performs pathogen genome sequencing and has efficiently developed a diagnostic package for the SARS-CoV-2 virus, which has been recognised internationally and authorized for its use worldwide. Furthermore, BGI sequenced and efficiently developed diagnostic kits for the SARS virus and avian influenza in 2000 and 2004 respectively.

In 2017, BGI Genomics, a subsidiary of BGI, established the three way partnership, Bangkok Genomics Innovation Co., Ltd., to pursue offering screening Non-invasive Prenatal Genetic Testing (NIFTY) and different Non-Invasive Prenatal Testing (NIPT) companies. The corporate, which went public as Bangkok Genomics Innovation Public Firm Restricted in 2022, applies fashionable ideas and applied sciences to supply medical companies in Thailand to develop efficient

healthcare service methods. For its half, Bangkok Genomics Innovation Public Firm Restricted helps the sector of precision drugs utilizing utilized science and know-how to help the event of focused and particular medical remedies to information prognosis and remedy choices for higher outcomes and illness prevention.